Kenneth Danh

Enable Biosciences (United States)

Papers

1

Total Citations

32

H-Index

1

About

Kenneth Danh has made pivotal contributions to the field of serological diagnostics, particularly in the urgent context of the COVID-19 pandemic. His research centers on the development and validation of high-throughput, automated platforms for antibody detection, addressing critical needs in infectious disease surveillance and public health response. Danh’s most-cited work, a 2020 study on a fully automated liquid-handling robotic system for SARS-CoV-2 antibody testing, has garnered 32 citations for its demonstration of sensitive and specific serological assays capable of large-scale community screening. This achievement directly supported efforts to assess infection prevalence and identify convalescent plasma donors during the early global outbreak. By integrating robotics with immunoassay technology, Danh’s contributions have advanced the speed and reliability of pandemic diagnostics, enabling more efficient population-level monitoring. His work exemplifies the intersection of engineering and immunology, providing a scalable model for future outbreak responses. With a focus on translational impact, Danh continues to shape the landscape of automated clinical testing, offering researchers and students a compelling example of how innovative laboratory solutions can meet real-world health crises.

Research Focus

Key Achievements

1
H-Index
1
Papers
32
Total Citations
32
Avg Citations/Paper
🏆 Most Cited Paper
Sensitive and Specific Detection of SARS-CoV-2 Antibodies Using a High-Throughput, Fully Automated Liquid-Handling Robotic System
32 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Enable Biosciences (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 3 days ago